Is UNII-5B2658E0N2 Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use UNII-5B2658E0N2? Is UNII-5B2658E0N2 safe for nursing mother and child? Does UNII-5B2658E0N2 extracts into breast milk? Does UNII-5B2658E0N2 has any long term or short term side effects on infants? Can UNII-5B2658E0N2 influence milk supply or can UNII-5B2658E0N2 decrease milk supply in lactating mothers?
UNII-5B2658E0N2 lactation summary
- DrLact safety Score for UNII-5B2658E0N2 is 1 out of 8 which is considered Safe as per our analyses.
- A safety Score of 1 indicates that usage of UNII-5B2658E0N2 is mostly safe during lactation for breastfed baby.
- Our study of different scientific research also indicates that UNII-5B2658E0N2 does not cause any serious side effects in breastfeeding mothers.
- Most of scientific studies and research papers declaring usage of UNII-5B2658E0N2 safe in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About UNII-5B2658E0N2 usage in lactation
Drug related to same group of 5-UNII-5B2658E0N2 It is excreted in tiny amounts into breast milk with no reported cases of harm effects except a case of mild gastroenteritis.
Answer by DrLact: About UNII-5B2658E0N2 usage in lactation
Limited information indicates that maternal UNII-5B2658E0N2 therapy produces low levels in milk and would not be expected to cause any adverse effects in breastfed infants, especially if the infant is older than 2 months. Exclusively breastfed infants should be monitored for rare instances of jaundice, gastrointestinal disturbances, hypokalemia, thrombocytopenia, hemolysis and hypokalemia if this drug is used during lactation.[1]
UNII-5B2658E0N2 Side Effects in Breastfeeding
UNII-5B2658E0N2 was used as part of multi-drug regimens to treat 2 pregnant women with multidrug-resistant tuberculosis throughout pregnancy and postpartum. Their two infants were breastfed (extent and duration not stated). At age 1.8 and 4.6 years, the children were developing normally, except for except for a mild speech delay in one at age 1.8 years, and failure to thrive in the other, possibly due to tuberculosis contracted after birth.[2]
Alternate Drugs
Rifabutin(Low Risk)
Capreomycin(Low Risk)
Rifampin(Safe)
Pyrazinamide(Safe)
Isoniazid(Safe)
Streptomycin(Safe)